Skip to main content
. 2015 Aug 1;6(29):28312–28326. doi: 10.18632/oncotarget.4873

Figure 7. DDX5 and DDX17 expression after treatment with RK-33.

Figure 7

A. DDX5 expression before and after DDX3 inhibition with RK-33. B. DDX17 expression before and after DDX3 inhibition with RK-33.